BABA vs HDL

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

HDL exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a conservative debt-to-equity ratio of 0.58, significantly outperforming sector averages in profitability and leverage. However, the stock is trading at a severe premium to its Graham Number ($4.43) and Intrinsic Value ($7.00), suggesting a valuation disconnect. While analyst targets remain bullish ($18.60), the technical trend is aggressively bearish (0/100) with consistent price declines over the last year. The company is a fundamentally sound business currently trapped in a bearish price cycle and overvalued relative to defensive metrics.